Akura Medical’s Post

This morning our Head of Research Colin Smith initiated coverage 📓 of Polarean (LSE: POLX). Despite initial FDA approval and grant of the requisite reimbursement codes, investor confidence in #POLX is low, as reflected in the current share price. However, revenue growth is already accelerating and is set to go hyperbolic as Polarean’s Xenon MRI platform meets a large unmet clinical need that cannot be satisfied by other methods. Crossing the bridge to profitability will require additional funding but there is a cash runway through 1Q26. Polarean has potential upside many times its current market cap, we calculate, based on observable deal metrics and our NPV analysis, while the valuation is so low, it could attract take-over interest, we believe. The purpose of AIM-listed Polarean is to revolutionise pulmonary medicine through direct visualisation of lung function, thereby radically improving patient care. You can read the full note below or on our portal: https://lnkd.in/e6BWF_iM #Research #Equities #UKEquities #AIM #investmentresearch #healthcare #LungMRI #PulmonaryImaging #XenonMRI #AdvancedDiagnostics

Check out our latest clinical study, the RECOIL Study! #Serranator demonstrated 89% less average recoil than POBA in the tibial arteries. "RECOIL in BTK and BTA vessels are an issue even after long-time standard balloon angioplasty (POBA)," states Dr. Michael Lichtenberg. Check out his case example of a recoil-free outcome in the plantar arch after utilizing Serranator. https://lnkd.in/eTgAmkgx Full publication of this core lab adjudicated study can be found here: https://lnkd.in/eJCqrFyG

Don't miss out on valuable insights from experts like Ivaan Gabric, MD, from Eye Clinic Svetjlost, Croatia, as they discuss the benefits of the SCHWIND ATOS. Learn about the adoption of lenticule extraction in a high-volume clinic and how it can benefit you. Watch the full presentation by following the link below! https://hubs.li/Q02nNpkl0 #schwind #schwindlaser #ophthalmology #refractive #schwindatos #smartsight

In this segment of "Our MELAS Story," the Sterchi family talks about Brady's abilities, their commitment to clinical trials, and their Hope for the Future. Watch the full video and learn more about #MELAS at umdf.org/MELAS

Although MELAS is rare, it is one of the most common mitochondrial diseases. MELAS is a progressive multisystem disorder that mainly affects the nervous system and muscles. It was the subject of my thesis. It is a pleasure to share information that helps raise awareness about this disease. #raredisease #mitochondrialdiseases

Si farvel til kateterrelaterte komplikasjoner! 🇧🇻 This week, our scientific expert Monika Harkin attended a training workshop in Trondheim, Norway, along with our partner Mathias Fossland from Scan-Med. a|s Norway. 📝 Around 150 medical professionals came to expand their knowledge on the management of central-venous catheters. Of course, the topic of catheter-related complications – and how to prevent them – was at the forefront. 💡 We’re excited to see more and more research findings on the efficacy of taurolidine-based lock solutions being published! #tauropharm #taurolock #taurolidine #antimicrobial #infectionprevention

For more information on this Oral Abstract where GOG-0724 will be presented during the 2024 ASCO Annual Meeting, go to https://ow.ly/3NML50RUlVV or click in bio. #clinicaltrials #GOGF #GOGPartners #GynecologicOncology #ASCO24

We're thrilled to share that our roadmap on Medical Applications of Ionising Radiation for Better Patient's Lives, developed within our #EURAMED #roccnroll project, has been published by the Directorate-General for Research and Innovation. 📈🔬 This roadmap is a testament to our commitment to advancing patient-centric approaches in medical research. It outlines eight potential breakthroughs poised to significantly impact the use of ionising radiation in healthcare, emphasising improvements in patient outcomes, radiation protection, and healthcare systems. 👉 Dive into the details here: https://lnkd.in/dNJ73epr #Euratom #H2020 #ProjectOutput #ImpactfulResearch #MedicalResearch #IonisingRadiation #Healthcare

#ewimed Report 2024: Today with insights into the ewimed patient questionnaire 📊 To further develop the treatment of #pleural effusion and #ascites, we have been collecting data during 14 years by means of an ewimed patient questionnaire. To gather this kind of data, patients were asked about various demographic and medical aspects, such as their age, gender or underlying diseases, during our patient training sessions, In our new ewimed report 2024, you will find a detailed evaluation of these patient questionnaires, covering a period of 5 years, from 2019 - 2023. This and other useful topics can be found in the ewimed report 2024 - download for free now: German website https://lnkd.in/eiN-bj8H French website https://lnkd.in/gXPpwb2e Italian website https://lnkd.in/gAHP8RnE #ewimed #ewimedswitzerland #patientquestionnaire #report #medicaltechnology #catheter #drainage #palliative #palliativecare